Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus

Completed · Not applicable

Conditions studied: Atrial Fibrillation, Atrial Flutter

In brief

The purpose of this study is to compare standard manual and robotically controlled catheter ablation of the cavo-tricuspid isthmus (CTI) as a treatment for atrial flutter. Ablation of the CTI is standard treatment for patients with a history of atrial flutter, and those undergoing ablation for atrial fibrillation. Both manual and robotic catheter manipulation are used in standard clinical practice at The University of California, San Diego (UCSD) for ablation.

Key facts

Study ID

NCT02467179

Run by

University of California, San Diego

People needed

50

Starts

2015-03-01

Expected to finish

2018-03-30

Last updated by the study team

2019-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be scheduled to undergo radiofrequency catheter ablation of the cavo-tricuspid isthmus for atrial fibrillation (AF) or atrial flutter (AFL) according to appropriate clinical indications.
• Must be able and willing to provide written informed consent
• Must be at least 18 years old.

You may not qualify if…

• Patient's refusal to participate in the study
• Lack of indication for CTI ablation (eg: prior CTI ablation with persistent bidirectional isthmus block)
• Pregnancy

Where it is running

• Sulpizio Cardiovascular Center — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.